Comments
Loading...

Legend Biotech (LEGN) Stock Price, Quote, News & History

LEGNNASDAQ
Logo brought to you by Benzinga Data
$22.14
0.030.14%
At close: Jan 15, 4:00 PM EST
$21.84
-0.27-1.22%
Pre-Market: 7:59 AM EST
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Key Statistics

Open
-
Close
$22.14
Volume / Avg.
3.50K / 1.99M
Day Range
- - -
52 Wk Range
20.21 - 45.30
Market Cap
$4.01B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
41
Short Interest
18.51%
Days to Cover
10.48

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-170.07M
Investing Cash Flow (TTM)
-16.73M
Financing Cash Flow (TTM)
14.00K
Free Cash Flow (TTM)
-188.68M
Capital Expenditure (TTM)
-18.61M
Net Change in Cash (TTM)
-186.79M

Analyst Trends and Forecast

4
Aug 25
2
Oct 25
3
Nov 25
3
Dec 25
1
Jan
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$3.51B
PE Ratio (TTM)
-
PE Ratio (FWD)
47.17
PEG Ratio (TTM)
-
PS Ratio (TTM)
4.48
PB Ratio (TTM)
4.04
Earnings Yield % (TTM)
-5.78%
Earnings Yield % (FWD)
2.12%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$5.48

Company Debt

Total Debt
$314.80M
LT Debt
$171.93M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$3.58M
Total Cash
$278.89M
Debt to Equity
0.41
Issuance of Debt (TTM)
-$3.58M
Repayment of Debt (TTM)
-$3.58M

Key Statistics

Open
-
Close
$22.14
Volume / Avg.
3.50K / 1.99M
Day Range
- - -
52 Wk Range
20.21 - 45.30
Market Cap
$4.01B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
41
Short Interest
18.51%
Days to Cover
10.48

About

Sector
Health Care
Industry
Biotechnology
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen rece...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
LEGN
IMVT

FAQ

Q

How do I buy Legend Biotech (LEGN) stock?

A

You can purchase shares of Legend Biotech (NASDAQ:LEGN) through any online brokerage.

View our list of the best stock brokerages

Q

What is the forecast, or price target, for Legend Biotech (LEGN) stock?

A

Legend Biotech has a consensus price target of $73.25.

Q

What is the current price for Legend Biotech (LEGN)?

A

The stock price for Legend Biotech (NASDAQ: LEGN) is $21.84 last updated January 20, 2026 at 8:02 AM EST.

Q

Does Legend Biotech (LEGN) pay a dividend?

A

There are no upcoming dividends for Legend Biotech.

Q

When is Legend Biotech (NASDAQ:LEGN) reporting earnings?

A

Legend Biotech does not have any upcoming earnings scheduled.

Q

Is Legend Biotech (LEGN) going to split?

A

There is no upcoming split for Legend Biotech.

Q

What sector and industry does Legend Biotech (LEGN) operate in?

A

Legend Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.